	Survival Outcomes Associated With Short-Acting Versus Long-Acting G-CSF Use During First-Line Chemoimmunotherapy for Advanced Lung Cancer: A Retrospective Study. Int J Cancer Xiong Y, Guo W, Ma C, Ren X, Sun Q. PMID: 42463467 [PubMed - as supplied by publisher]
	How hypoxia and mechanics drive lung cancer progression. Acta Biomater Kasturi M, Novak CM. PMID: 42463068 [PubMed - as supplied by publisher]
	Evolving Lung Cancer Navigator Practice Through Targeted Professional Development: A Long-term Outcomes Analysis. Chest Lloyd SJ, Mortman MF, Monahan PO, Slaven JE, Lemery C, Podsiad M, Barry AM, Weston SA, Boyd AS, Fathi JT. PMID: 42463006 [PubMed - as supplied by publisher]
	A hydrogen sulfide activated fluorescence probe for screening tumor cells and diagnosis of non-small cell lung carcinoma. J Photochem Photobiol B Si W, Guo Z, Zhang Y, Meng D, Liu S, Zhang Z, Ma J. PMID: 42462551 [PubMed - as supplied by publisher]
	Exploring decisional needs of adults considering first line treatment for advanced EGFR+ lung cancer: An interpretive descriptive study. Cancer Treat Res Commun Seeger R, Stacey D, Bossio E, Wheatley-Price P. PMID: 42462368 [PubMed - as supplied by publisher]
	Chemoimmunotherapy Versus Chemotherapy for Extensive-Stage Small Cell Lung Cancer in the Real-World Setting: Retrospective Study of 904 Patients. Clin Lung Cancer Dimitriou K, Shi S, Marginenau A, Blasi M, Bozorgmehr F, Klotz LV, Eichhorn F, Schneider MA, Allgäuer M, Shah R, Bischoff H, Weykamp F, Stenzinger A, Thomas M, Christopoulos P. PMID: 42462290 [PubMed - as supplied by publisher]
	Quality of Life, Symptom Burden, and Associated Factors Among Patients With Lung Cancer in Sub-Saharan Africa: Cross-Sectional Study. JMIR Cancer Ratshikana M, Malale K, Sayed AR, Ayeni O, Mathobela P, Mathiba R, Blanchard C, Tsitsi M, Osei-Fofie D, Graham A, Dhudha HO, Masalu N. PMID: 42462209 [PubMed - in process]
	Evaluating Large Reasoning Models Versus Human Multidisciplinary Teams in Lung Cancer Decision-Making: Real-World Study. J Med Internet Res Viculin I, Vrdoljak J, Tomi, Canjko I, , , Bo, Dru, Vukovi, Dunkic N, Popovi, Mladinov S, Bo, Vrdoljak E. PMID: 42461960 [PubMed - indexed for MEDLINE]
	Surveillance Imaging Findings of Lung Cancer Recurrence after Definitive Therapy. Radiographics Anwar R, Brown A, Hsu WC, Shi V, Masuodi B, Oncel D, Ha J, Harowicz MR, Voong KR, Illei PB, Lin CT. PMID: 42461758 [PubMed - indexed for MEDLINE]
	Socioeconomic Disparities in Lung Cancer Screening Participation. JAMA Netw Open Delilovic S, Yacaman Mendez D, Markholm Nordgren N, Wagenius G, Richter A. PMID: 42461629 [PubMed - indexed for MEDLINE]
	Machine Learning-Based Prediction of Brain Metastasis at Initial Diagnosis in Small-Cell Lung Cancer: Model Development and SHAP Interpretation Study. Cancer Rep (Hoboken) He YL, Jiang QL, Zhai Y, Zhao XL, Huang ZK. PMID: 42461209 [PubMed - indexed for MEDLINE]
	A plain language summary of the SAVANNAH study: savolitinib plus osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification whose cancer had grown or spread on osimertinib. Future Oncol de Marinis F, Kim TM, Bonanno L, Cheng S, Kim SW, Tiseo M, Chu Q, Proto C, Sacher A, Luo YH, Novello S, Hao D, Baik C, Bazhenova L, Lee JS, Cho BC, Cadranel J, Diep TB, Metro G, Narayanan P, Yoneshima Y, de Castro Carpeño J, Baldotto C, Yang JC, Sequist LV, Levy B, Hartmaier R, Igwegbe I, Poole L, Xu W, Ahn MJ. PMID: 42460617 [PubMed - as supplied by publisher]
	Bone health in neuroendocrine tumors and prognostic implications beyond skeletal metastases. Front Endocrinol (Lausanne) Casabella A, Hasballa I, Arecco A, Boschetti M, Della Sala L, Demontis D, Sulli A, Vera L, Veresani A, Ferone D, Paolino S, Albertelli M. PMID: 42460322 [PubMed - indexed for MEDLINE]
	Plasma HERV-K envelopE RNA: a minimally invasive biomarker for lung adenocarcinoma detection and prognostic assessment in the context of conventional serum tumor markers. Front Immunol Bu F, Jin ZY, Ling ZQ. PMID: 42459690 [PubMed - indexed for MEDLINE]
	Extracellular vesicles as prognostic biomarkers: results of a neoadjuvant chemoimmunotherapy clinical trial in stage IIIA (N2) non-small-cell lung cancer (SAKK 16/14). Front Immunol da Silva Y, Chiang DM, Benecke L, Pfaffl MW, Hayoz S, Chiquet S, Prince SS, Bettini A, Früh M, Mauti LA, Britschgi C, Peters S, Mark M, Ochsenbein AF, Janthur WD, Waibel C, Mach N, Froesch P, Buess M, Bohanes P, Gonzalez M, Zippelius A, Pless M, Rothschild SI, Muller L. PMID: 42459666 [PubMed - indexed for MEDLINE]
	Efficacy and safety of first-line chemoimmunotherapy versus chemotherapy alone for advanced pulmonary lymphoepithelioma-like carcinoma: a systematic review and real-world cohort study. Front Immunol Chen F, Su Y, Zeng X, Jiang M, Huang Y, Pan L, Xiao L, Qin YR, Cen X, Bai J. PMID: 42459654 [PubMed - indexed for MEDLINE]
	Molecular and metabolic dysregulation of lung cancer in developing anti-tumor activity by gambogic acid mediated mTOR signaling: in vitro and computational study. 3 Biotech Bo S, Liao Y, Chen X, Liu L, Pang F, Zhou L. PMID: 42459409 [PubMed]
	Comparison of Procedural Safety and Diagnostic Yield Between Robotic-Assisted Bronchoscopy Platforms. J Bronchology Interv Pulmonol Nauka PC, Nouraie SM, Tepper J, Yacono P, Vercauteren M, Schuchert M, Dhupar R, Dunlap DG, Semaan R. PMID: 42459019 [PubMed - indexed for MEDLINE]
	Correlation of programmed death cell ligand-1 expression in non-small cell lung cancer between small biopsy and surgical specimens. Pol J Pathol Aleksi, Tegeltija D, Aleksi, , Miki. PMID: 42458972 [PubMed - indexed for MEDLINE]
	Prognostic impact of spread through air spaces and its association with KRAS mutation and histopathologic factors in resected colorectal lung metastases. Pol J Pathol Geçmen GG, Hallaç Keser S, Ece D, Çoban Kökten , Çimeno, Güler A, Pala A, Sensu S. PMID: 42458968 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 161552

Page 1 of 8078



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy